Role of residual acute stent malapposition in percutaneous coronary interventions
- 15 March 2017
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 90 (4), 566-575
- https://doi.org/10.1002/ccd.26974
Abstract
Assess clinical consequences of acute stent malapposition (ASM) in the context of the multicenter Centro per la Lotta Contro l'Infarto-Optimization of Percutaneous Coronary Intervention (CLI-OPCI) registry. ASM as important determinant of stent thrombosis (ST) risk remains controversial. From 2009 to 2013, we retrospectively analyzed postprocedural optical coherence tomography (OCT) findings in 864 patients undergoing percutaneous coronary intervention, assessing prevalence and magnitude of ASM and exploring correlation with outcome, especially ST. Postprocedural OCT revealed a variable grade of ASM in 72.3% of stents without correlation between maximal strut-vessel distance and longitudinal extension (R = 0.164, P < 0.01). At a median follow up of 302 (IQ 127–567) days, ASM did not affect risk of following major cardiac adverse events (MACE); residual ASM was comparable in terms of thickness (median [quartiles] 0.21[IQ 0.1–0.4] vs. 0.20[IQ 0.0–0.3], P = 0.397) and length (2.0[IQ 0.5–4.1] vs. 2.2[IQ 0.0–5.2], P = 0.640) in patients with versus without MACE. The predictive accuracy for outcome was low (C-statistic 0.52, CI 95% 0.47–0.58, P = 0.394) as well for target lesion revascularization (HR 0.80, CI 95% 0.5–1.4) and ST (HR 0.71, CI 95% 0.3–1.5). Likewise, timing to MACE was not influenced by presence of such an ASM with similar rate of acute-subacute (HR 1.09, CI 95% 0.6–1.9), late (HR 0.91, CI 95% 0.5–1.8), and very late (HR 1.23, CI 95% 0.5–2.9) events. Limited ASM was a common finding after stent implantation, but was not associated to increased risk of stent failure or ST during mid-term follow-up.Keywords
This publication has 34 references indexed in Scilit:
- Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence TomographyCirculation, 2016
- Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES studyCatheterization and Cardiovascular Interventions, 2016
- Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers RegistryCirculation: Cardiovascular Interventions, 2015
- Randomized comparison of acute stent malapposition between platinum–chromium versus cobalt–chromium everolimus-eluting stentsThe International Journal of Cardiovascular Imaging, 2014
- Outcomes of everolimus-eluting stent incomplete stent apposition: a serial optical coherence tomography analysisEuropean Heart Journal – Cardiovascular Imaging, 2014
- Incidences, Predictors, and Clinical Outcomes of Acute and Late Stent Malapposition Detected by Optical Coherence Tomography After Drug-Eluting Stent ImplantationCirculation: Cardiovascular Interventions, 2014
- Pathology of Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in HumansCirculation, 2014
- Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting StentsThe New England Journal of Medicine, 2007
- Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary StentsThe New England Journal of Medicine, 2007
- Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting StentsJama-Journal Of The American Medical Association, 2005